Group One Trading, L.P. Allakos Inc. Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Allakos Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 118,153 shares of ALLK stock, worth $33,082. This represents 0.01% of its overall portfolio holdings.
Number of Shares
118,153
Previous 98,649
19.77%
Holding current value
$33,082
Previous $64,000
121.88%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALLK
# of Institutions
79Shares Held
68.8MCall Options Held
20.9KPut Options Held
0-
Bvf Inc San Francisco, CA16.6MShares$4.63 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.72 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.6 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.02 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.01 Million0.01% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $23.7M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...